These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 12824968

  • 1. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations.
    ASCUS-LSIL Traige Study (ALTS) Group.
    Am J Obstet Gynecol; 2003 Jun; 188(6):1393-400. PubMed ID: 12824968
    [Abstract] [Full Text] [Related]

  • 2. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.
    ASCUS-LSIL Traige Study (ALTS) Group.
    Am J Obstet Gynecol; 2003 Jun; 188(6):1383-92. PubMed ID: 12824967
    [Abstract] [Full Text] [Related]

  • 3. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.
    Guido R, Schiffman M, Solomon D, Burke L, ASCUS LSIL Triage Study (ALTS) Group.
    Am J Obstet Gynecol; 2003 Jun; 188(6):1401-5. PubMed ID: 12824969
    [Abstract] [Full Text] [Related]

  • 4. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.
    Cox JT, Schiffman M, Solomon D, ASCUS-LSIL Triage Study (ALTS) Group.
    Am J Obstet Gynecol; 2003 Jun; 188(6):1406-12. PubMed ID: 12824970
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).
    Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ, ALTS Group.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):92-100. PubMed ID: 16418511
    [Abstract] [Full Text] [Related]

  • 6. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 18; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 7. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
    Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT, Gafni A.
    CMAJ; 2000 Sep 19; 163(6):701-7. PubMed ID: 11022584
    [Abstract] [Full Text] [Related]

  • 8. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
    Wu HH, Allen SL, Kirkpatrick JL, Elsheikh TM.
    Diagn Cytopathol; 2006 Oct 19; 34(10):707-10. PubMed ID: 16955480
    [Abstract] [Full Text] [Related]

  • 9. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A.
    J Reprod Med; 2001 Sep 19; 46(9):799-805. PubMed ID: 11584480
    [Abstract] [Full Text] [Related]

  • 10. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.
    J Natl Cancer Inst; 2009 Dec 02; 101(23):1612-23. PubMed ID: 19903804
    [Abstract] [Full Text] [Related]

  • 11. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S.
    Asian Pac J Cancer Prev; 2014 Dec 02; 15(24):10961-6. PubMed ID: 25605209
    [Abstract] [Full Text] [Related]

  • 12. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 13. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.
    Solomon D, Schiffman M, Tarone R, ALTS Study group.
    J Natl Cancer Inst; 2001 Feb 21; 93(4):293-9. PubMed ID: 11181776
    [Abstract] [Full Text] [Related]

  • 14. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, Cao J, Jiang Y, Zhao FH, Qiao YL.
    Gynecol Oncol; 2014 May 21; 133(2):172-9. PubMed ID: 24631450
    [Abstract] [Full Text] [Related]

  • 15. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan 21; 41(1):34-7. PubMed ID: 16635326
    [Abstract] [Full Text] [Related]

  • 16. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
    Alonso I, Torné A, Puig-Tintoré LM, Esteve R, Quinto L, Garcia S, Campo E, Pahisa J, Ordi J.
    Am J Obstet Gynecol; 2007 Oct 21; 197(4):359.e1-6. PubMed ID: 17714678
    [Abstract] [Full Text] [Related]

  • 17. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias.
    Sherman ME, Wang SS, Tarone R, Rich L, Schiffman M.
    Cancer Epidemiol Biomarkers Prev; 2003 Apr 21; 12(4):372-9. PubMed ID: 12692113
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J.
    Acta Obstet Gynecol Scand; 2016 Nov 21; 95(11):1220-1227. PubMed ID: 27591407
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 20. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J.
    Diagn Cytopathol; 2017 May 09; 45(5):384-390. PubMed ID: 28247516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.